Home » Topics » BioWorld Science

BioWorld Science
RSS

First-in-human data presented for tetrameric bispecific antibody AK-104

Nov. 18, 2019

Results presented from proof-of-concept phase I study of cenerimod

Nov. 18, 2019

Positive results presented from second phase III psoriasis study of bimekizumab

Nov. 18, 2019

Anchiano discontinues phase II Codex study of inodiftagene vixteplasmid in NMIBC

Nov. 18, 2019

New PEGylated IL-2 with improved pharmacologic properties specifically activates and expands Tregs

Nov. 18, 2019

New Smo antagonist shows antitumor activity in medulloblastoma and cholangiocarcinoma animal models

Nov. 18, 2019

HPN-328 targeting DLL3 shows preclinical efficacy and safety for immunotherapy in SCLC

Nov. 18, 2019

Roche presents first-in-human data for RO-7062931

Nov. 18, 2019

resTORbio stops development of RTB-101 for clinically symptomatic respiratory illness

Nov. 15, 2019

Interim data presented from phase I study of TK-216 in Ewing's sarcoma

Nov. 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...